Please Wait...

Michele Steinmetz

Translation skills

Main profile

Michele Steinmetz
Michele Steinmetz
Lead Clinical Research Coordinator, General Medicine, Psychiatry & Pain

Michele is a Certified Clinical Research Coordinator who has been working at Bioclinica’s Orlando site for over five years. Michele has been focused on the NASH field since 2017 and has led the enrollment of 10 NASH trials during that time. Besides NASH, Michele has also worked on a variety of other indications, including Alzheimer’s Disease, Atopic Dermatitis, Depression, Diabetes, Insomnia, Osteoarthritis, Overactive Bladder and PTSD. Prior to entering the research field, Michele obtained a Bachelor’s degree in Biochemistry from Loyola University Maryland and a Master’s degree in Public Health Preparedness from Pennsylvania State University.

Blogs

Non-alcoholic fatty liver disease (NAFLD) and its progression to non-alcoholic steatohepatitis (NASH), is estimated to become the most common chronic liver condition in Western populations. It has been difficult for researchers and policymakers to accurately estimate the prevalence of NAFLD/NASH because the diseases are asymptomatic.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

David Scott, PhD, Bioclinica Dir Medical & Science Affairs, will present on longitudinal progression of DaTscan bin… https://t.co/CA1LnzLZBs
Bioclinica (3 hours ago)
In our latest blog post, we review the "burdens" of #CTMS implementation - and how better solutions address them.… https://t.co/vcyS2gvwpu
Bioclinica (5 days ago)
David Scott, PhD, Bioclinica Dir Medical & Science Affairs, will present on longitudinal progression of DaTscan bin… https://t.co/01liAxqx0J
Bioclinica (6 days ago)
Rapid implementation. Increased control & efficiency. Out-of-the-box configuration. Turn-key validation. Cost savin… https://t.co/XO53jwd2DV
Bioclinica (2 weeks ago)
David Scott, PhD, Bioclinica Dir Medical & Science Affairs, will present on longitudinal progression of DaTscan bin… https://t.co/ZtxVWMlznP
Bioclinica (2 weeks ago)
Bioclinica's #IRT uses an agile delivery methodology, which means flexible configuration and customization, and del… https://t.co/SRd2uNscWc
Bioclinica (2 weeks ago)